Member of doctoral thesis juries at Vrije Universiteit Brussel-Belgium

​

• Schallier A.; “Discovery of glutamate transporters as novel drug targets for epilepsy and Alzheimer’s disease” (2011); Promoters: Prof. Dr. I. Smolders and Dr. A. Massie; Co-promoter: Prof. Dr. Y. Michotte.

• Alaerts G.; “Chromatographic fingerprints of herbal extracts as tools for identification or quality control” (2012); Promoters: Prof. Dr. Y. Vander Heyden and Prof. Dr. J. Smeyers-Verbeke; Co-promoter: Dr. B. Dejaegher.

• De Geyter D.; “The effects of systemic administration of the insulin-like growth factor-I in a rat model for ischemic stroke” (2012); Promoter: Prof. Dr. R. Kooijman; Co-promoter: Prof. Dr. J. De Keyser.

• Guimarães E.; “Investigation of mechanisms in hepatic stellate cell activation in vitro” (2012); Promoter: Prof. Dr. L. van Grunsven.

• Loyens E.; “The role of insulin-regulated aminopeptidase and its substrates in mechanisms of epilepsy and antidepressant-like activity” (2012); Promoter: Prof. Dr. I. Smolders; Co-promoters: Prof. Dr. Y. Michotte and Prof. Dr. P. Vanderheyden.

• Vermoesen K..; “Evaluation of the convulsant liability and antiepileptic properties of antidepressant” (2012); Promoter: Prof. Dr. R. Clinckers; Co-promoters: Prof. Dr. I. Smolders and Prof. Dr. A. Massie.

• Van Haute L.; “Human embryonic stem cells as a paradigm for disease modelling in respiration” (2013); Promoter: Prof. Dr. K. Sermon; Co-promoter: Prof. Dr. M. De Rycke.

• Schroyen B.; “The role of leptin, insulin and insulin-like growth factor binding protein 3 during hepatic stellate cell activation” (2014); Promoter: Prof. Dr. L. van Grunsven; Co-promoter: Prof. Dr. M. Nyssen.

• Varçin M.; “Oxidative stress, PINK1 and neuroprotection in experimental models of Parkinson’s disease” (2014); Promoter: Prof. Dr. Y. Michotte; Co-promoter: Dr. S. Sarre.

• Baert Y.; “In vitro systems to restore male fertility following testicular tissue banking” (2016); Promoter: Prof. Dr. E. Goossens.

• Bentea E.; “Targeting the cystine/glutamate antiporter for neuroprotection: insights from mouse models of Parkinson’s disease” (2016); Promoter: Prof. Dr. A. Massie; Co-promoter: Prof. Dr. I. Smolders.

• Buyl K.; “Characterization and reprogramming of umbilical cord-derived mesenchymal stromal cells towards the hepatic lineage” (2017); Promoters: Prof. Dr. J. De Kock, Prof. Dr. T. Vanhaecke and Prof. Dr. V. Rogiers.

• Leclercq K.; “Development of preclinical models of treatment-resistant epilepsy for application in future antiepleptic drug discovery” (2017); Promoter: Prof. Dr. I. Smolders; Co-promoter: Dr. R. Kaminski.

• Albertini G.; “Glial modulators of extracellular glutamate and their involvement in pathological behavior” (2018); Promoters: Prof. Dr. I. Smolders and Prof. Dr. A. Massie.

• De Prins A.; “Development and biological evaluation of neuromedin U analogs as tools for functional elucidation: focus on stress-related disorders” (2018); Promotors: Prof. Dr. I. Smolders and Prof. Dr. S. Ballet; Co-promotors: Prof. Dr. A. Van Eeckhaut, Prof. Dr. D. De Bundel and Prof. Dr. V. Caveliers.

• Laeremans T.; “The role of natural killer cells in functional cure strategies against human immunodeficiency virus type 1 infection” (2023); Promotors: Prof. Dr. J. Aerts and Prof. Dr. S. Allard; Co-promotor: Prof. Dr. G. Vanham.

​​

Member of doctoral thesis juries at other Belgian universities

​

• Wynant I.; “Heterologous expression systems for the production of metabolites during early drug research” (2010); Promoter: Prof. Dr. L. Droogmans; Co-promoters: Prof. Dr. J.-P. Simon and Dr. H. Bohets; Institut de Recherchers Microbiologiques, Université Libre de Bruxelles-Belgium.

• Bol M.; “Modulation of the vascular function by cannabinoids, calcitonin gene related peptide and connexin hemichannels” (2013); Promoter: Prof. Dr. L. Leybaert; Co-promoter: Prof. Dr. B. Vanheel; Department of Basic Medical Sciences, Universiteit Gent-Belgium.

• Oorts M.; “Understanding drug-induced cholestasis: mechanistic exploration of hepatic bile acid disposition” (2017); Promoter: Prof. Dr. P. Annaert; Co-promoter: Prof. Dr. L. Richert; Department of Pharmaceutical and Pharmacological Sciences, Katholieke Universiteit Leuven-Belgium.

• Iyyathurai J.; “The regulation of Cx43-hemichannel function by intramolecular interactions via the SH3-binding domain and by autophagy” (2017); Promoter: Prof. Dr. G. Bultynck; Department of Cellular and Molecular Medicine, Katholieke Universiteit Leuven-Belgium.

• Ramadan R.; “The role of intercellular communication in radiation-induced atherosclerosis” (2019); Promoter: Prof. Dr. L. Leybaert and Dr. A. Aerts; Department of Basic Medical Sciences, Universiteit Gent-Belgium.

• Ghosh S.; “Use of iPSC-derived hepatocyte-like cells for hepatotoxicity testing” (2023); Promotor: Prof. Dr. M. C. Verfaillie; Department of Development and Regeneration Stem Cell Biology and Embryology, Katholieke Universiteit Leuven-Belgium; Co-promotor: Prof. Dr. M. T. D. Cronin; Liverpool John Moores University-United Kingdom.

​

Member of doctoral thesis juries at non-Belgian universities

​

• Jetten M.; “Toxicogenomics responses in the in vitro liver: a view on human interindividual variation” (2014); Promoter: Prof. Dr. J.C.S. Kleinjans; Department of Toxicogenomics, Universiteit Maastricht-The Netherlands.

• Gago Fuentes R.; “Role of the C-terminal tail of Cx43 in adult articular chondrocytes” (2016); Promoter: Prof. Dr. M.D. Mayan Santos and Prof. Dr. F.J. Blanco Garcia; Instituto de Investigación Biomédica, Universidade da Coruña-Spain.

• Hiemstra S.; “High throughput microscopy of mechanism-based reporters of drug-induced liver injury” (2016); Promoter: Prof. Dr. B. van de Water; Leiden Academic Center for Drug Research, Universiteit Leiden-The Netherlands.

• Vatakuti S.; “Toxicogenomics of precision-cut liver slices for prediction of human liver toxicity: a prevalidation study” (2016); Promoters: Prof. Dr. G.M.M. Groothuis and Prof. Dr. P. Olinga; Department of Pharmacy, Rijksuniversiteit Groningen-The Netherlands.

• Jiang J.; “Mechanisms of drug induced liver injury: toxicogenomics studies in different in vitro models” (2017); Promoter: Prof. Dr. T. de Kok; Department of Toxicogenomics, Universiteit Maastricht-The Netherlands.

• Hendriks D.; “Hepatic 3D spheroids as a model system for drug-induced liver injury and cytochrome P450 induction” (2018); Promoter: Prof. Dr. M. Ingelman-Sundberg; Co-promoters: Prof. Dr. I. Johansson and Prof. Dr. S. Mkrtchian; Department of Physiology and Pharmacology, Karolinska Institute-Sweden.

• Wolters J.; “Toxicogenomics approaches in vitro for unraveling the mechanisms for hepatotoxicity” (2018); Promoter: Prof. Dr. J. Kleinjans; Department of Toxicogenomics, Universiteit Maastricht-The Netherlands.

• Verheijen M.; “Transcriptomics close to my heart: advanced models and methods for toxicogenomics research  illustrated by anthracycline-induced cardiotoxicity” (2019); Promoter: Prof. Dr. J. Kleinjans; Co-promotor: Prof. Dr. F. Caiment; Department of Toxicogenomics, Universiteit Maastricht-The Netherlands.

• O'Donovan S.D.; “Modelling the dynamics in time-series of metabolomic and transcriptomic data” (2020); Promoters: Prof. T. de Kok, Prof. R. Peeters, Prof. N. van Riel and Prof. I. Arts; Department of Toxicogenomics, Universiteit Maastricht-The Netherlands.

• Kasteel E.E.J.; “Next generation risk assessment of chemicals: in vitro and in silico approaches to work towards enough precision to make a decision” (2021); Promoter: Prof. Dr. J. Legler; Co-promoters: Dr. N. Kramer and Dr. R. Westerink; Faculty of Veterinary Sciences, Utrecht University-The Netherlands.

• Wellens S.; “Differentiation of brain like endothelial cells from iPSC and application to BBB toxicity testing” (2021); Promoter: Prof. Dr.  M. Culot; Université d’Artois-France.

• Kralj T.; “Multi-omics characterisation of drug-induced liver injury in human-derived hepatocyte models” (2021); Promoters: Prof. Dr. D. Creek and Prof. Dr. K. Brouwer; Monash University-Australia.

• Cox C.; “Evaluating the role of mitochondrial genetics in adverse-drug reactions and the application of iPSC-derived hepatocytes for modelling drug-induced liver injury” (2023); Dr. P. Sharma, Dr. A. Chadwick and Prof. Dr. C. Goldring; University of Liverpool-United Kingdom.

• Rasool N.; “Pharmacological and toxicological evaluation of Argyrolobium Roseum (Camb.) Jaub and Spach extracts against lead induced hepato-renal toxicity in rodents" (2023); Prof. Dr. M. Ovais Omer; University of Veterinary and Animal Sciences-Pakistan.

• Lavriha P.; “Molecular mechanisms of connexin-32 gating” (2023); Prof. Dr. V. Korkhoven, Prof. Dr. M. Pilhofer and Prof. Dr. M. Peter; Swiss Federal Institute of Technology-Switzerland.

• Wang Z.; “Intrahepatic cholangiocyte organoids for bile-duct tissue engineering and disease modeling” (2023); Promoters: Prof. Dr. R. Masereeuw and Dr. B. Spee; Faculty of Sciences, Utrecht University-The Netherlands.

• de Bruijn V.M.P.; "New approach methodologies (NAMs) to understand and predict drug-induced effects on bile acid homeostasis and cholestasis" (2024); Promoters: Prof. Dr. I.M.C.M. Rietjens and Dr. H. Bouwmeester; Wageningen University-The Netherlands.

• Martens M.; “Adverse outcome pathways coming to life: exploring new ways to support risk assessments” (2024); Promotors: Prof. Dr. C.T. Evelo and Dr. E.L. Willighagen; Maastricht University-The Netherlands.

• Kuo C.; “Exploring the role of the inflammasome pathway in diabetic retinopathy” (2024); Promotors: Dr. L. Mugisho, Prof. Dr. I. Rupenthal and Prof. Dr. Murphy; University of Auckland-New Zealand.